These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31497752)

  • 21. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5.
    Schweiger M; Lass A; Zimmermann R; Eichmann TO; Zechner R
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E289-96. PubMed ID: 19401457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and functional insights into ABHD5, a ligand-regulated lipase co-activator.
    Tseng YY; Sanders MA; Zhang H; Zhou L; Chou CY; Granneman JG
    Sci Rep; 2022 Feb; 12(1):2565. PubMed ID: 35173175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2.
    Peng Y; Miao H; Wu S; Yang W; Zhang Y; Xie G; Xie X; Li J; Shi C; Ye L; Sun W; Wang L; Liang H; Ou J
    Autophagy; 2016 Nov; 12(11):2167-2182. PubMed ID: 27559856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics.
    Yang A; Mottillo EP
    Biochem J; 2020 Mar; 477(5):985-1008. PubMed ID: 32168372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CGI-58/ABHD5 is phosphorylated on Ser239 by protein kinase A: control of subcellular localization.
    Sahu-Osen A; Montero-Moran G; Schittmayer M; Fritz K; Dinh A; Chang YF; McMahon D; Boeszoermenyi A; Cornaciu I; Russell D; Oberer M; Carman GM; Birner-Gruenberger R; Brasaemle DL
    J Lipid Res; 2015 Jan; 56(1):109-21. PubMed ID: 25421061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity.
    Caviglia JM; Betters JL; Dapito DH; Lord CC; Sullivan S; Chua S; Yin T; Sekowski A; Mu H; Shapiro L; Brown JM; Brasaemle DL
    J Lipid Res; 2011 Nov; 52(11):2032-42. PubMed ID: 21885429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function.
    Pingitore P; Pirazzi C; Mancina RM; Motta BM; Indiveri C; Pujia A; Montalcini T; Hedfalk K; Romeo S
    Biochim Biophys Acta; 2014 Apr; 1841(4):574-80. PubMed ID: 24369119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans.
    Peter A; Kovarova M; Nadalin S; Cermak T; Königsrainer A; Machicao F; Stefan N; Häring HU; Schleicher E
    Diabetologia; 2014 Oct; 57(10):2103-7. PubMed ID: 24972532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling.
    Lord CC; Brown JM
    Adipocyte; 2012; 1(3):123-131. PubMed ID: 23145367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease.
    Huang Y; Cohen JC; Hobbs HH
    J Biol Chem; 2011 Oct; 286(43):37085-93. PubMed ID: 21878620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Genetic Variant I148M in PNPLA3 Is Associated With Increased Hepatic Retinyl-Palmitate Storage in Humans.
    Kovarova M; Königsrainer I; Königsrainer A; Machicao F; Häring HU; Schleicher E; Peter A
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1568-74. PubMed ID: 26439088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABHD5 stimulates PNPLA1-mediated ω-
    Kien B; Grond S; Haemmerle G; Lass A; Eichmann TO; Radner FPW
    J Lipid Res; 2018 Dec; 59(12):2360-2367. PubMed ID: 30361410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of PNPLA3 in health and disease.
    Pingitore P; Romeo S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):900-906. PubMed ID: 29935383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chanarin-Dorfman syndrome: deficiency in CGI-58, a lipid droplet-bound coactivator of lipase.
    Yamaguchi T; Osumi T
    Biochim Biophys Acta; 2009 Jun; 1791(6):519-23. PubMed ID: 19061969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL.
    Witzel HR; Schwittai IMG; Hartmann N; Mueller S; Schattenberg JM; Gong XM; Backs J; Schirmacher P; Schuppan D; Roth W; Straub BK
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of lipolytic protein trafficking and interactions in adipocytes.
    Granneman JG; Moore HP; Granneman RL; Greenberg AS; Obin MS; Zhu Z
    J Biol Chem; 2007 Feb; 282(8):5726-35. PubMed ID: 17189257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABHD5-A Regulator of Lipid Metabolism Essential for Diverse Cellular Functions.
    Schratter M; Lass A; Radner FPW
    Metabolites; 2022 Oct; 12(11):. PubMed ID: 36355098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Micro RNA-124a regulates lipolysis via adipose triglyceride lipase and comparative gene identification 58.
    Das SK; Stadelmeyer E; Schauer S; Schwarz A; Strohmaier H; Claudel T; Zechner R; Hoefler G; Vesely PW
    Int J Mol Sci; 2015 Apr; 16(4):8555-68. PubMed ID: 25894224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2.
    Lu X; Yang X; Liu J
    Cell Cycle; 2010 Jul; 9(14):2719-25. PubMed ID: 20676045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.
    Yu L; Li Y; Grisé A; Wang H
    Adv Exp Med Biol; 2020; 1276():197-222. PubMed ID: 32705602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.